REQUEST A DEMO
Total
USD $0.00
Search more companies

Syntalpharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Toilet Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Chemical and Allied Products Merchant Wholesalers | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Other Personal and Household Goods Repair and Maintenance
Full name: Syntalpharma Sp. z o.o. Profile Updated: April 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

SyntalPharma Sp Z O O is a company specializing in developing technology for the production of intermediates and active ingredients for pharmaceutical and cosmetic industries. They focus on research and development and offer products for use in these industries.

Headquarters
Ul. Labedzka 59
Gliwice; Slaskie; Postal Code: 44-121

Contact Details: Purchase the Syntalpharma Sp. z o.o. report to view the information.

Website: http://www.syntalpharma.com

Basic Information
Total Employees:
Purchase the Syntalpharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Syntalpharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Syntalpharma Sp. z o.o. report to view the information.
Incorporation Date:
April 03, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
45%
Purchase this report to view the information.
45%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Syntalpharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
37.41%
Total operating revenue
37.41%
Net Profit (Loss) for the Period
43.56%
Total assets
19.86%
Total equity
76.31%
Net Profit Margin
1.55%
Return on Equity (ROE)
-16.43%
Debt to Equity Ratio
-96.6%
Quick Ratio
172.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?